L-Nutra Health has launched a clinician-supervised fasting mimicking diet program in London, extending a US model built on periodic cycles of a patented plant-based protocol for patients with type 2 diabetes and obesity. Supporting evidence includes a 12-month randomized controlled trial in Dutch primary care published in Diabetes Care, where participants adding the diet to usual care showed better glycemic control and reduced glucose-lowering medication use. The announcement originates from the company selling the product, and no pricing or enrollment figures were disclosed.
Key Points
- Clinician-supervised fasting mimicking program launches in UK medical practices
- Randomized trial showed improved glycemic control, less diabetes medication
- Company-issued announcement; no cost or enrollment figures disclosed
Longevity Analysis
Periodic caloric restriction cycles act on the same metabolic machinery that drives age-related decline: insulin signaling, nutrient sensing, and the cellular clearance processes that resume when feeding stops. Positioning this alongside GLP-1 pharmacotherapy addresses a structural gap, since medication alters appetite without rebuilding the eating patterns underneath it. The clinical model matters as much as the protocol itself, because lab review, medication adjustment, and repeated cycles over months determine whether a short-term metabolic shift becomes a durable one.
Original published by Longevity.Technology, by Kyle Umipig.